IPP Bureau
Merck launches international platform to discuss ‘Next-Gen Labs’
By IPP Bureau - July 06, 2022
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
Cipla updates on US FDA product-specific pre-approval inspection
By IPP Bureau - July 06, 2022
The company has received 2 observations on FDA Form 483 with respect to ANDA filed for the product to be manufactured at Indore plant.
Biocon Biologics receives EU GMP Certification for its in Bengaluru
By IPP Bureau - July 06, 2022
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
Krsnaa Diagnostics opens diagnostics center at Moga, Punjab
By IPP Bureau - July 06, 2022
Krsnaa Diagnostics now has its footprints in Delhi.
Regeneron completes purchase of Sanofi's stake in Libtayo
By IPP Bureau - July 06, 2022
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
CEPI and Codiak BioSciences partner to develop protective Betacoronavirus vaccine
By IPP Bureau - July 06, 2022
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Vacuubrand unveils new corporate identity
By IPP Bureau - July 06, 2022
VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering
StimLabs announces new placental membrane-based product ‘Enverse’
By IPP Bureau - July 06, 2022
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
By IPP Bureau - July 06, 2022
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Apollo Hospitals bags Waterfalls Global Award
By IPP Bureau - July 06, 2022
Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
By IPP Bureau - July 06, 2022
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
By IPP Bureau - July 06, 2022
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
.jpg "ART Fertility Clinics appoints Dr. Somesh Mittal as CEO, India")
ART Fertility Clinics appoints Dr. Somesh Mittal as CEO, India
By IPP Bureau - July 05, 2022
Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.
50% of heart attacks now happens in Indians below 50 years: says Expert
By IPP Bureau - July 05, 2022
Younger Indians have a 10 times higher rate of heart attack
